This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Edwards Webinar: Advances in Valve Tissue Technology and Why It Matters
CTSNet once more hosted a webinar in collaboration with Edwards Lifesciences on the pivotal topic, "Advances in Valve Tissue Technology and Why It Matters." The webinar launched to a live audience on May 16, 2023. The professional panel featured renowned global leaders in cardiac surgery, including Joseph Bavaria, MD (Vice-Chief Pennsylvania Cardiovascular Surgery, 52nd President of the STS); Michael Borger, MD (Director of Cardiac Surgery, Leipzig Heart Center); and Thomas Beaver, MD, MPH (Grant and Shirle Herron Chair, Professor and Chief of Cardiovascular Surgery, University of Florida College of Medicine).
- RESILIA tissue science and technology
- Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis
- Five-year COMMENCE aortic trial BAV data in context of lifetime management of younger patients
- Aortic stenosis: lifetime patient management and guidelines
The panelists also opened the discussion to attendee questions in an extensive Q&A session.
For more content like this, be sure to also check out the Edwards Learning Network, available at edwards.com/learning as well as in the Apple and Google Play stores.
Please note that not all products and/or techniques discussed in this video are approved for use globally and may not be approved/available in your country/region.
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.